Neogen Chemicals Intrinsic Value
Neogen Chemicals (NEOGEN) median intrinsic value is ₹618.84 from 9 valuation models (range ₹413–₹1031), vs current price ₹2062.80 — -70.0% downside (Trading Above Calculated Value), margin of safety -100.0%. Read NEOGEN dividend growth for the complete payout history and dividend yield track record.
NEOGEN Valuation Methods Summary — DCF, Graham Number & P/E
Neogen Chemicals intrinsic value across 9 models vs current price ₹2062.80 — upside/downside and value range per method. For current market price and key ratios, visit NEOGEN share price screener.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹618.84 | ₹495.07 - ₹742.61 | -70.0% | EPS: ₹17.28, Sector P/E: 12x |
| Book Value Method | asset | ₹412.56 | ₹371.30 - ₹453.82 | -80.0% | Book Value/Share: ₹313.85, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹618.84 | ₹556.96 - ₹680.72 | -70.0% | Revenue/Share: ₹381.54, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹825.12 | ₹742.61 - ₹907.63 | -60.0% | EBITDA: ₹180.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹1023.97 | ₹819.18 - ₹1228.76 | -50.4% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹618.84 | ₹556.96 - ₹680.72 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹618.84 | ₹556.96 - ₹680.72 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹1031.40 | ₹928.26 - ₹1134.54 | -50.0% | ROE: 5.4%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹618.84 | ₹556.96 - ₹680.72 | -70.0% | EPS: ₹17.28, BVPS: ₹313.85 |
NEOGEN Intrinsic Value vs Market Price — All Valuation Models
Neogen Chemicals fair value range ₹413–₹1031 vs current market price ₹2062.80 across 9 valuation models. Analyse NEOGEN FII DII holdings to track promoter, FII and institutional holdings.
NEOGEN Intrinsic Value Analysis — Undervalued or Overvalued?
Neogen Chemicals median intrinsic value ₹618.84, current price ₹2062.80 — Trading Above Calculated Value by 70.0%, margin of safety -100.0%.
What is the intrinsic value of NEOGEN?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Neogen Chemicals (NEOGEN) is ₹618.84 (median value). With the current market price of ₹2062.80, this represents a -70.0% variance from our estimated fair value.
The valuation range spans from ₹412.56 to ₹1031.40, indicating ₹412.56 - ₹1031.40.
Is NEOGEN undervalued or overvalued?
Based on our multi-method analysis, Neogen Chemicals (NEOGEN) appears to be trading above calculated value by approximately 70.0%.
NEOGEN Financial Health — Key Ratios vs Industry Benchmarks
Neogen Chemicals financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 1.55 | Industry Standard: 2.0+ | Above 1.5 | Measures short-term liquidity capacity |
| Return on Equity | 5.4% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 18.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.34x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
NEOGEN Cash Flow Quality — Operating & Free Cash Flow
Neogen Chemicals operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹196 Cr | ₹38 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹-29 Cr | ₹-137 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹-30 Cr | ₹-78 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹1 Cr | ₹-72 Cr | Positive Operating Cash Flow | 6/10 |
| March 2021 | ₹84 Cr | ₹17 Cr | Positive Free Cash Flow | 7/10 |